Table 1

Adiposity and cardiometabolic risk markers: overall and by sex

Boys (n=2158)Girls (n=2337)All participants (n=4495)
Geometric mean (95% CI)
 Ponderal index (kg/m3)13.0 (13.0 to13.1)13.2 (13.1 to 13.3)13.1 (13.1 to 13.2)
 Sum of skinfolds (mm)36.7 (35.9 to 37.6)45.7 (44.7 to 46.7)41.1 (40.4 to 41.9)
 Fat mass index (kg/m5)1.91 (1.87 to 1.94)2.17 (2.13 to 2.21)2.04 (2.01 to 2.07)
 HbA1c (%)5.24 (5.22 to 5.26)5.25 (5.23 to 5.26)5.24 (5.23 to 5.26)
 Glucose (mmol/L)4.56 (4.54 to 4.58)4.47 (4.45 to 4.49)4.51 (4.50 to 4.53)
 Insulin (mU/L)6.46 (6.23 to 6.69)8.14 (7.86 to 8.43)7.28 (7.07 to 7.51)
 HOMA-IR0.82 (0.79 to 0.85)1.02 (0.99 to 1.06)0.92 (0.89 to 0.95)
 Leptin (ng/mL)7.15 (6.83 to 7.48)11.49 (11.00 to 12.00)9.15 (8.83 to 9.48)
 C reactive protein (mg/L)0.44 (0.42 to 0.47)0.57 (0.54 to 0.60)0.50 (0.48 to 0.53)
 Triglycerides (mmol/L)0.76 (0.74 to 0.77)0.85 (0.84 to 0.87)0.81 (0.79 to 0.82)
 HDL cholesterol (mmol/L)1.53 (1.51 to 1.54)1.44 (1.42 to 1.45)1.48 (1.47 to 1.49)
 LDL cholesterol (mmol/L)2.60 (2.57 to 2.64)2.60 (2.57 to 2.63)2.60 (2.58 to 2.63)
 Total cholesterol (mmol/L)4.53 (4.49 to 4.56)4.47 (4.44 to 4.50)4.50 (4.47 to 4.52)
Mean (95% CI)
 Systolic BP (mm Hg)105.2 (104.6 to 105.7)104.2 (103.7 to 104.8)104.7 (104.2 to 105.2)
 Diastolic BP (mm Hg)62.8 (62.3 to 63.3)63.0 (62.5 to 63.5)62.9 (62.4 to 63.3)
 Daily counts*437 416 (429 717 to 445 114)362 857 (355 382 to 370 332)397 973 (391 604 to 404 342)
 Daily time spent in MVPA (mins)*78.4 (75.9 to 80.9)61.6 (59.1 to 64.1)69.5 (67.1 to 71.9)
  • Means (geometric means) adjusted for sex (all participants), age (quartiles), ethnic group, month and a random effect to allow for clustering within schools.

  • *Based on 2031 participants with data for daily counts and time spent in MVPA, the numbers for each screen time group were as follows: none=80, an hour or less=729, 1–2 hours=593, 2–3 hours=270, more than 3 hours=359.

  • Geometric means are presented for log-transformed variables.

  • BP, blood pressure; HDL, high-density lipoprotein; HOMA, homeostasis model assessment; IR, insulin resistance; LDL, low-density lipoprotein; MVPA, moderate-to-vigorous physical activity.